A detailed history of New York State Common Retirement Fund transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 12,075 shares of BIO stock, worth $3.99 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,075
Previous 13,831 12.7%
Holding current value
$3.99 Million
Previous $3.78 Million 6.96%
% of portfolio
0.01%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$263.97 - $344.64 $463,531 - $605,187
-1,756 Reduced 12.7%
12,075 $4.04 Million
Q2 2024

Jul 31, 2024

SELL
$268.26 - $339.48 $59,285 - $75,025
-221 Reduced 1.57%
13,831 $3.78 Million
Q1 2024

May 07, 2024

SELL
$304.11 - $351.99 $581,154 - $672,652
-1,911 Reduced 11.97%
14,052 $4.86 Million
Q4 2023

Feb 01, 2024

SELL
$269.37 - $365.04 $489,175 - $662,912
-1,816 Reduced 10.21%
15,963 $5.15 Million
Q3 2023

Nov 07, 2023

SELL
$350.25 - $422.63 $1.38 Million - $1.67 Million
-3,946 Reduced 18.16%
17,779 $6.37 Million
Q2 2023

Aug 07, 2023

SELL
$359.49 - $486.4 $185,856 - $251,468
-517 Reduced 2.32%
21,725 $8.24 Million
Q1 2023

May 02, 2023

SELL
$418.69 - $503.0 $416,596 - $500,485
-995 Reduced 4.28%
22,242 $10.7 Million
Q4 2022

Jan 30, 2023

BUY
$351.71 - $456.01 $169,875 - $220,252
483 Added 2.12%
23,237 $9.77 Million
Q3 2022

Nov 08, 2022

SELL
$412.59 - $563.26 $807,438 - $1.1 Million
-1,957 Reduced 7.92%
22,754 $9.49 Million
Q2 2022

Aug 04, 2022

SELL
$463.67 - $597.16 $331,060 - $426,372
-714 Reduced 2.81%
24,711 $12.2 Million
Q1 2022

May 05, 2022

SELL
$524.57 - $735.42 $1.11 Million - $1.55 Million
-2,110 Reduced 7.66%
25,425 $14.3 Million
Q4 2021

Feb 02, 2022

SELL
$708.84 - $794.68 $184,298 - $206,616
-260 Reduced 0.94%
27,535 $20.8 Million
Q3 2021

Nov 02, 2021

SELL
$657.71 - $825.77 $465,658 - $584,645
-708 Reduced 2.48%
27,795 $20.7 Million
Q2 2021

Aug 02, 2021

BUY
$576.64 - $649.04 $593,362 - $667,862
1,029 Added 3.75%
28,503 $18.4 Million
Q1 2021

May 11, 2021

SELL
$547.01 - $662.35 $1.09 Million - $1.32 Million
-2,000 Reduced 6.79%
27,474 $15.7 Million
Q4 2020

Feb 08, 2021

SELL
$510.68 - $643.45 $8.74 Million - $11 Million
-17,105 Reduced 36.72%
29,474 $17.2 Million
Q3 2020

Nov 05, 2020

SELL
$454.43 - $535.6 $1.82 Million - $2.14 Million
-4,000 Reduced 7.91%
46,579 $24 Million
Q2 2020

Aug 07, 2020

BUY
$334.87 - $493.06 $3.14 Million - $4.62 Million
9,379 Added 22.76%
50,579 $22.8 Million
Q1 2020

May 06, 2020

BUY
$320.01 - $409.07 $704,022 - $899,954
2,200 Added 5.64%
41,200 $14.4 Million
Q4 2019

Feb 05, 2020

SELL
$319.73 - $374.2 $639,460 - $748,400
-2,000 Reduced 4.88%
39,000 $14.4 Million
Q3 2019

Nov 07, 2019

BUY
$304.55 - $345.24 $60,910 - $69,048
200 Added 0.49%
41,000 $13.6 Million
Q2 2019

Aug 09, 2019

SELL
$286.93 - $312.59 $373,009 - $406,366
-1,300 Reduced 3.09%
40,800 $12.8 Million
Q1 2019

May 08, 2019

SELL
$224.3 - $317.41 $4.18 Million - $5.92 Million
-18,644 Reduced 30.69%
42,100 $12.9 Million
Q4 2018

Feb 08, 2019

SELL
$220.1 - $309.0 $627,285 - $880,650
-2,850 Reduced 4.48%
60,744 $14.1 Million
Q3 2018

Nov 07, 2018

SELL
$289.28 - $326.15 $4.5 Million - $5.08 Million
-15,567 Reduced 19.66%
63,594 $19.9 Million
Q2 2018

Aug 10, 2018

SELL
$244.1 - $303.88 $1.38 Million - $1.72 Million
-5,648 Reduced 6.66%
79,161 $22.8 Million
Q1 2018

May 10, 2018

BUY
$233.97 - $274.11 $678,513 - $794,919
2,900 Added 3.54%
84,809 $21.2 Million
Q4 2017

Feb 13, 2018

BUY
$216.94 - $271.3 $145,349 - $181,771
670 Added 0.82%
81,909 $19.5 Million
Q3 2017

Nov 06, 2017

BUY
$212.27 - $242.28 $992,999 - $1.13 Million
4,678 Added 6.11%
81,239 $18.1 Million
Q2 2017

Aug 11, 2017

BUY
N/A
76,561
76,561 $17.3 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.14B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.